These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 28575099)

  • 1. Differential stability of therapeutic peptides with different proteolytic cleavage sites in blood, plasma and serum.
    Böttger R; Hoffmann R; Knappe D
    PLoS One; 2017; 12(6):e0178943. PubMed ID: 28575099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of intrinsic proteolytic activities moderates preanalytical variability and instability of human plasma.
    Yi J; Kim C; Gelfand CA
    J Proteome Res; 2007 May; 6(5):1768-81. PubMed ID: 17411080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sample collection in clinical proteomics--proteolytic activity profile of serum and plasma.
    Jambunathan K; Galande AK
    Proteomics Clin Appl; 2014 Jun; 8(5-6):299-307. PubMed ID: 24723329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minimizing preanalytical variation of plasma samples by proper blood collection and handling.
    Yi J; Craft D; Gelfand CA
    Methods Mol Biol; 2011; 728():137-49. PubMed ID: 21468945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombin induces broad spectrum proteolysis in human serum samples.
    O'Mullan P; Craft D; Yi J; Gelfand CA
    Clin Chem Lab Med; 2009; 47(6):685-93. PubMed ID: 19099528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptidomic analysis of human blood specimens: comparison between plasma specimens and serum by differential peptide display.
    Tammen H; Schulte I; Hess R; Menzel C; Kellmann M; Mohring T; Schulz-Knappe P
    Proteomics; 2005 Aug; 5(13):3414-22. PubMed ID: 16038021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of fluorination on proteolytic stability of peptides in human blood plasma.
    Asante V; Mortier J; Schlüter H; Koksch B
    Bioorg Med Chem; 2013 Jun; 21(12):3542-6. PubMed ID: 23623671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating peptide half-life in serum from tunable, sequence-related physicochemical properties.
    Cavaco M; Valle J; Flores I; Andreu D; A R B Castanho M
    Clin Transl Sci; 2021 Jul; 14(4):1349-1358. PubMed ID: 33641212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro metabolic stability of iodinated obestatin peptides.
    De Spiegeleer B; Van Dorpe S; Vergote V; Wynendaele E; Pauwels E; Van De Wiele C; Garcia-Solis P; Solis-Sainz JC
    Peptides; 2012 Feb; 33(2):272-8. PubMed ID: 22222609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrinsic peptidase activity causes a sequential multi-step reaction (SMSR) in digestion of human plasma peptides.
    Yi J; Liu Z; Craft D; O'Mullan P; Ju G; Gelfand CA
    J Proteome Res; 2008 Dec; 7(12):5112-8. PubMed ID: 19367699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of a serum stability tag for bioactive peptides.
    Jambunathan K; Galande AK
    Protein Pept Lett; 2014; 21(1):32-8. PubMed ID: 24354769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An in vitro selection strategy for conferring protease resistance to ligand binding peptides.
    Eldridge B; Cooley RN; Odegrip R; McGregor DP; Fitzgerald KJ; Ullman CG
    Protein Eng Des Sel; 2009 Nov; 22(11):691-8. PubMed ID: 19755412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic peptides and peptidomimetics as substrates and inhibitors of thrombin and other proteases in the blood coagulation system.
    Claeson G
    Blood Coagul Fibrinolysis; 1994 Jun; 5(3):411-36. PubMed ID: 8075312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial peptides with stability toward tryptic degradation.
    Svenson J; Stensen W; Brandsdal BO; Haug BE; Monrad J; Svendsen JS
    Biochemistry; 2008 Mar; 47(12):3777-88. PubMed ID: 18307313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MS-based monitoring of proteolytic decay of synthetic reporter peptides for quality control of plasma and serum specimens.
    Findeisen P; Thumfart JO; Costina V; Hofheinz R; Neumaier M
    Am J Clin Pathol; 2013 Sep; 140(3):314-23. PubMed ID: 23955449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Degradation and Stabilization of Peptide Hormones in Human Blood Specimens.
    Yi J; Warunek D; Craft D
    PLoS One; 2015; 10(7):e0134427. PubMed ID: 26222180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial peptides are degraded by the cytosolic proteases of human erythrocytes.
    Starr CG; Wimley WC
    Biochim Biophys Acta Biomembr; 2017 Dec; 1859(12):2319-2326. PubMed ID: 28912099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability and degradation patterns of chemically modified analogs of apelin-13 in plasma and cerebrospinal fluid.
    Murza A; Belleville K; Longpré JM; Sarret P; Marsault É
    Biopolymers; 2014 Jul; 102(4):297-303. PubMed ID: 24728860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conditions for collection of serum samples for the measurement of fibrin(ogen) degradation products by radioimmunoassay of fragment E.
    Martin MJ; Gordon YB; Ratky SM; Baker LR; Chard T
    J Clin Pathol; 1976 Apr; 29(4):336-40. PubMed ID: 932225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved proteolytic stability of chicken cathelicidin-2 derived peptides by D-amino acid substitutions and cyclization.
    Molhoek EM; van Dijk A; Veldhuizen EJ; Haagsman HP; Bikker FJ
    Peptides; 2011 May; 32(5):875-80. PubMed ID: 21376095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.